Literature DB >> 2684595

Guidelines for treating hypertension in the elderly.

J P Emeriau1.   

Abstract

The incidence of hypertension increases with ageing, and one-third of the elderly population is affected. The role of hypertension as a cardiovascular risk factor has been confirmed in the elderly by the incidence of stroke and myocardial infarction. Effective treatment of hypertension significantly reduces the risk of associated complications: cardiovascular death, congestive heart failure and stroke. There are numerous secondary effects of antihypertensive treatment and the prescription and monitoring of treatment should take into account potential effects specific to elderly patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2684595     DOI: 10.2165/00003495-198938040-00007

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  24 in total

1.  Effects of treatment on morbidity in hypertension. 3. Influence of age, diastolic pressure, and prior cardiovascular disease; further analysis of side effects.

Authors: 
Journal:  Circulation       Date:  1972-05       Impact factor: 29.690

Review 2.  Hypertension. Definitions, natural histories and consequences.

Authors:  G Pickering
Journal:  Am J Med       Date:  1972-05       Impact factor: 4.965

3.  Epidemiology of stroke in an elderly welfare population.

Authors:  A M Ostfeld; R B Shekelle; H Klawans; H M Tufo
Journal:  Am J Public Health       Date:  1974-05       Impact factor: 9.308

4.  Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg.

Authors: 
Journal:  JAMA       Date:  1967-12-11       Impact factor: 56.272

Review 5.  Antihypertensive treatment according to age, plasma renin and race.

Authors:  F R Bühler
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

Review 6.  Diuretics. Clinical pharmacology and therapeutic use (Part II).

Authors:  A Lant
Journal:  Drugs       Date:  1985-02       Impact factor: 9.546

7.  Treatment of arterial hypertension by penta- and hexamethonium salts; based on 150 tests on hypertensives of varied aetiology and 53 patients treated for periods of two to fourteen months.

Authors:  F H SMIRK; K S ALSTAD
Journal:  Br Med J       Date:  1951-06-02

8.  Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). The IPPPSH Collaborative Group.

Authors: 
Journal:  J Hypertens       Date:  1985-08       Impact factor: 4.844

9.  MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-13

10.  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Authors: 
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

View more
  3 in total

Review 1.  Antihypertensive therapy in the aged patient. Clinical pharmacokinetic considerations.

Authors:  R W Piepho; K J Fendler
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

Review 2.  Epidemiology of hypertension in the elderly.

Authors:  N Morgenstern; R L Byyny
Journal:  Drugs Aging       Date:  1992 May-Jun       Impact factor: 3.923

3.  Serum concentration-effect relationship of (+/-)-nicardipine and nifedipine in elderly hypertensive patients.

Authors:  H C Porchet; F Loew; L Gauthey; P Dayer
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.